Author

Quoc Thang Bui

University of PennsylvaniaORCID 0009-0008-8169-0248Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Serge Yu. FuchsiD· 3 shared Yingying Tang· 3 shared Ágnes HolczbaueriD· 2 shared Ben Z. StangeriD· 2 shared Constantinos KoumenisiD· 2 shared John Alan DiehliD· 2 shared Mayura R. DhamdhereiD· 2 shared Raghavendra BasavarajaiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Serge Yu. FuchsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyNature CancerPeer-reviewedOct 30, 2026

Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6).

Charline Ogier, Charles Solomon Akino Mercy, Elena Bondarenko…·Igor A. Astsaturov

This study identifies ANO6-mediated trogocytosis as a mechanism by which CAFs transfer lipids to PDAC cells, promoting tumor growth and immune suppression.

28 citationstop 1%

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 3, 2026

Mono-ADP-ribosylation-driven immunosuppression and cross-resistance to therapy through cancer cell intrinsic and extrinsic mechanisms

Yuchen Sun, Yingying Tang, Vivek T. Singh…·Serge Yu. Fuchs

This study shows that PARP11-induced MARylation and ubiquitination of MHC-I in cancer cells promotes immunosuppression, tumor growth, and resistance to therapies.

DOI 10.64898/2026.06.01.729331

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 1, 2026

SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies

Quoc Thang Bui, Raghavendra Basavaraja, Mayura R. Dhamdhere…·Serge Yu. Fuchs

This study identifies SPTBN2 as a regulator of immunosuppressive tumor microenvironment and cross-resistance to therapies, showing its role in suppressing CAR T-cell efficacy.

DOI 10.64898/2026.03.30.715365

humanmouse

𝕏 PostBluesky